Abstract PR039
Reiko Oishi(Fukushima Medical University), Masahiro Murakawa(Fukushima Medical University), Norie Sanbe(Fukushima Medical University), Shunsuke Ohashi(Kyoto University), Shinichi Obara(Fukushima Medical University), Yoshihiro Noji(Fukui Prefectural Hospital), Hermine Fouda Ebana(Fukushima Medical University), Tsuyoshi Isosu(Fukushima Medical University)
Cited by 0
Related Papers
Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis
|Clinical Chemistry and Laboratory Medicine (CCLM)|2001|151
Increased Circulating Matrix Metalloproteinase-2 in Patients With Hypertrophic Cardiomyopathy With Systolic Dysfunction
|Circulation Journal|2004|76
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia
|Atherosclerosis|2002|74
Plasma ropivacaine concentration following ultrasound-guided subcostal transversus abdominis plane block in adults
|Journal of Anesthesia|2014|26
Venous Thromboembolism in Patents With Lung Cancer
|Clinical and Applied Thrombosis/Hemostasis|2020|25